Long-Term Safety of Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: Results from Phase 3 FREEDOMS II Extension Study

被引：0

作者：

Vollmer, Timothy ^{[1
]}

Jeffery, Douglas

Goodin, Douglas ^{[2
]}

Kappos, Ludwig ^{[3
]}

Lublin, Fred ^{[4
]}

Radue, Ernst-Wilhelm ^{[5
]}

Rammohan, Kottil ^{[6
]}

Reder, Anthony ^{[7
]}

Agius, Mark ^{[8
,9
]}

Stites, Tracy ^{[10
]}

Li, Bingbing ^{[10
]}

Cappiello, Linda ^{[11
]}

von Rosenstiel, Philipp ^{[12
]}

Calabresi, Peter ^{[13
]}

机构：

[1] Univ Colorado Denver, Aurora, CO USA

[2] Univ Calif San Francisco, San Francisco, CA 94143 USA

[3] Univ Basel Hosp, CH-4031 Basel, Switzerland

[4] Mt Sinai Med Ctr, Corinne Goldsmith Dickinson Ctr Multiple Sclerosi, New York, NY 10029 USA

[5] Univ Basel Hosp, Med Image Anal Ctr, Basel, Switzerland

[6] Univ Miami, Miami, FL USA

[7] Univ Chicago, Med Ctr, Oak Pk, IL USA

[8] Univ Calif Davis, Davis, CA 95616 USA

[9] VANCHCS, Davis, CA USA

[10] Novartis Pharmaceut, E Hanover, NJ USA

[11] Li Bingbing Bingbing Li Novartis Com, E Hanover, NJ USA

[12] Novartis Pharma AG, Basel, Switzerland

[13] Johns Hopkins Univ Hosp, MS Ctr, Baltimore, MD 21287 USA

来源：

NEUROLOGY | 2013年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P01165

引用

页数：2

共 50 条

[21] Long-term Efficacy and Safety of Fingolimod in Japanese Patients with Relapsing Multiple Sclerosis (MS): 3-year Results from a Phase 2 Extension Study
Kira, J.
Itoyama, Y.
Kikuchi, S.
Hao, Q.
Kurosawa, T.
Ueda, K.
Nagato, K.
Saida, T.
MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 928 - 929
[22] Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
Calabresi, Peter A.
Radue, Ernst-Wilhelm
Goodin, Douglas
Jeffery, Douglas
Rammohan, Kottil W.
Reder, Anthony T.
Vollmer, Timothy
Agius, Mark A.
Kappos, Ludwig
Stites, Tracy
Li, Bingbing
Cappiello, Linda
von Rosenstiel, Philipp
Lublin, Fred D.
LANCET NEUROLOGY, 2014, 13 (06): : 545 - 556
[23] Long-Term Efficacy, Safety and Tolerability of Ponesimod in Patients with Relapsing-Remitting Multiple Sclerosis
Freedman, Mark
Boster, Aaron
Fernandez, Oscar
Melanson, Maria
Pozzilli, Carlo
D'Ambrosio, Daniele
Sidorenko, Tatiana
Olsson, Tomas
NEUROLOGY, 2013, 80
[24] Real-life long-term effectiveness of fingolimod in Swiss patients with relapsing-remitting multiple sclerosis
Zecca, C.
Roth, S.
Findling, O.
Perriard, G.
Bachmann, V.
Pless, M. L.
Baumann, A.
Kamm, C. P.
Lalive, P. H.
Czaplinski, A.
EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (05) : 762 - 767
[25] Long-term safety and efficacy of ocrelizumab in patients with relapsing-remitting multiple sclerosis: week 144 results of a phase II, randomised, multicentre trial
Kappos, L.
Li, D.
Calabresi, P.
O'Connor, P.
Bar-Or, A.
Barkhof, F.
Wells, C.
Leppert, D.
Masterman, D.
Tinbergen, J.
Hauser, S. L.
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 140 - 141
[26] Long-term safety and efficacy of ocrelizumab in patients with relapsing-remitting multiple sclerosis: Week 144 results of a Phase II, randomised, multicentre trial
Kappos, L.
Bar-Or, A.
Sauter, A.
Leppert, D.
Li, D.
Masterman, D.
Barkhof, F.
Tinbergen, J.
O'Connor, P.
Calabresi, P. A.
Hauser, S. L.
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1875 - 1875
[27] Safety and tolerability of BG-12 in patients with relapsing-remitting multiple sclerosis: results from the phase 3 CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study
Havrdova, E.
Phillips, J. T.
Fox, R. J.
Miller, D.
Kita, M.
Hutchinson, M.
Raghupathi, K.
Yuan, H.
Novas, M.
Sweetser, M. T.
Viglietta, V.
Dawson, K. T.
JOURNAL OF NEUROLOGY, 2012, 259 : S105 - S105
[28] Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis
Montalban, Xavier
Comi, Giancarlo
Antel, Jack
O'Connor, Paul
de Vera, Ana
Cremer, Malika
Sfikas, Nikolaos
von Rosenstiel, Philipp
Kappos, Ludwig
JOURNAL OF NEUROLOGY, 2015, 262 (12) : 2627 - 2634
[29] Efficacy and safety of fingolimod in relapsing-remitting multiple sclerosis: results from a retrospective French cohort
Nerrant, E.
Labauge, P.
Brochet, B.
Thouvenot, E.
Ouallet, J-C.
Ayrignac, X.
Carra-Dalliere, C.
Castelnovo, G.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 572 - 573
[30] Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis
Xavier Montalban
Giancarlo Comi
Jack Antel
Paul O’Connor
Ana de Vera
Malika Cremer
Nikolaos Sfikas
Philipp von Rosenstiel
Ludwig Kappos
Journal of Neurology, 2015, 262 : 2627 - 2634

← 1 2 3 4 5 →